YEAR-END REPORT 1 OCTOBER – 31 DECEMBER 2017
Fourth quarter 2017, compared to 2016, Group » Gross order intake amounted to SEK 885,088 (626,306), an increase of 41,3% » Order backlog amounted to SEK 893,014 (325,434), an increase of 174,4% » 38% growth in orders for Episealer® knee implants during the quarter with 36 (26) approved orders » Group net sales amounted to SEK 884,088 (1,007,759) » Loss before tax amounted to SEK –15,547,283 (–18,454,211) » Loss per share (weighted average) amounted to SEK –0.51 (–0.97) Significant events during the fourth quarter » Episealer® 24 months’ clinical study results